Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Zai Lab Ltd

(NASDAQ: ZLAB)
Add to Portfolio
+0.97 (+1.88%)
as of 10:21 EDT

Last 52.52
Change +0.97 (+1.88%)
Open 53.17
Prev. Close 51.55
Today's Range
51.95
53.17
52wk Range
23.42
63.95
Volume 11201
Avg Volume 389720
Sector SIC-2834 Pharmaceutical Preparations

Perfomance Comparison

Name Today 3-Month 1-Year
ZLAB +1.88% -3.69% +67.47%
DJIA +5.24% -23.94% -16.56%
S&P 500 +5.00% -21.04% -10.05%

Key Statistics

Annual EPS N/A
Dividend Yield 0.00%
P/E Ratio N/A
Market Capitalization, $K 2991830
Weighted Alpha +60.40
Standard Deviation +0.32
Profit Margin N/A
Beta 0.96

Growth Rates

YTD +26.76%
1-Year +63.75%

Opinion

Sell Hold Buy

Recent Headlines

Zai Lab Announces Financial Results for Full Year

GlobeNewswire via COMTEX - Thu Mar 19, 07:30AM EDT
-- Company to Host Conference Call and Webcast Today at 8:30 a.m. EDT(full story)
ZLAB: 52.52 (+0.97)

Zai Lab Ltd. to Host Earnings Call

ACCESSWIRE via COMTEX - Thu Mar 19, 06:30AM EDT
NEW YORK, NY / ACCESSWIRE / March 19, 2020 / Zai Lab Ltd. (NASDAQ:ZLAB) will be discussing their earnings results in their 2019 Second Half Earnings call to be held on March 19, 2020 at 8:30 AM Eastern Time.(full story)
ZLAB: 52.52 (+0.97)

Zai Lab Announces Acceptance of sNDA Submission of

GlobeNewswire via COMTEX - Mon Mar 16, 07:30AM EDT
Zai Lab Limited (NASDAQ: ZLAB), a China and U.S.-based innovative commercial stage biopharmaceutical company, today announced the China National Medical Products Administration (NMPA) has accepted its supplemental New Drug Applica(full story)
ZLAB: 52.52 (+0.97)

Zai Lab to Announce Financial Results for the Full

GlobeNewswire via COMTEX - Thu Mar 05, 07:30AM EST
-- Company to host Conference Call and Webcast on March 19, 2020 at 8:30 a.m. ET(full story)
ZLAB: 52.52 (+0.97)

Zai Lab Announces Upcoming Participation at February

GlobeNewswire via COMTEX - Tue Feb 11, 07:30AM EST
Zai Lab Limited ("Zai Lab") (NASDAQ: ZLAB), a China and U.S.-based innovative commercial-stage biopharmaceutical company, today announced that Dr. Samantha Du, Founder and Chief Executive Officer, will be presenting at the followi(full story)
ZLAB: 52.52 (+0.97)